Ciltistotug
Based on 1 Customer Validation
Ciltistotug is a monoclonal antibody targeting human CD40 (TNFRSF5). Ciltistotug activates immune cells after binding to CD40, exerting immunostimulatory and antitumor activities. Ciltistotug is promising for research of cancer immunotherapy.
For research use only. We do not sell to patients.
- Purity: 95.376%
- CAS No.: 3014361-59-9
- Molecular Weight:144.954 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG2 kappa
Human
CD40
P25942-1
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG2-kappa
ELISA, FACS, Functional assay
-
Immobilized HY-P73499A CD40 Protein, Human (HEK293, His) can bind Ciltistotug. The EC50 for this effect is 23.16 ng/mL.
Chemical Information
-
CAS No. 3014361-59-9
-
Appearance Liquid
-
Molecular Weight 144.954 kDa
-
Color Colorless to light yellow
-
SMILES
[Ciltistotug]
-
Synonyms
YH003
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (254 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)